EPIQ Partners’s Cardiovascular Systems, Inc. CSII Stock Holding History

EPIQ Partners’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,411	Closed	-$246K	–	80
2023 Q1	$246K	Hold	12,411	–	–	0.17%	65
2022 Q4	$169K	Hold	12,411	–	–	0.11%	73
2022 Q3	$172K	Buy	12,411 +2,411	+24%	+$35.8K	0.11%	78
2022 Q2	$144K	Hold	10,000	–	–	0.09%	82
2022 Q1	$226K	Buy	+10,000	New	+$194K	0.12%	82
2021 Q4	–	Sell	-7,548	Closed	-$248K	–	96
2021 Q3	$248K	Hold	7,548	–	–	0.11%	84
2021 Q2	$322K	Buy	7,548 +1,548	+26%	+$60.5K	0.16%	69
2021 Q1	$230K	Hold	6,000	–	–	0.13%	79
2020 Q4	$263K	Hold	6,000	–	–	0.18%	64
2020 Q3	$224K	Buy	+6,000	New	+$194K	0.17%	69

Other funds holding CSII

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

EPIQ Partners's CSII Position: Q2 2023 in Review

EPIQ Partners sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 12,411 shares — an estimated $246K sold.

EPIQ Partners first reported a position in CSII in Q3 2020 and held it in 10 quarters. The position peaked at $322K in Q2 2021. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

EPIQ Partners reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
EPIQ Partners sold 12,411 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $246K.
EPIQ Partners first reported a position in Cardiovascular Systems, Inc. in Q3 2020 and held it in 10 quarters.
EPIQ Partners's Cardiovascular Systems, Inc. position peaked at $322K in Q2 2021.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on EPIQ Partners's 13F filing for Q2 2023, filed 12 Jul 2023.